Ignite Creation Date:
2025-12-24 @ 12:14 PM
Ignite Modification Date:
2026-01-21 @ 11:39 PM
Study NCT ID:
NCT02921061
Status:
COMPLETED
Last Update Posted:
2020-03-17
First Post:
2016-09-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDS
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-11-17
Start Date Type:
ACTUAL
Primary Completion Date:
2018-10-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-10-24
Completion Date Type:
ACTUAL
First Submit Date:
2016-09-29
First Submit QC Date:
None
Study First Post Date:
2016-09-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-10-24
Results First Submit QC Date:
None
Results First Post Date:
2020-03-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-21
Last Update Post Date:
2020-03-17
Last Update Post Date Type:
ACTUAL